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Abstract
Background: Accumulated literature suggests that the acidic nuclear phosphoprotein 32 kilodalton (Anp32) proteins
control multiple cellular activities through different molecular mechanisms. Like other Anp32 family members, Anp32e
(a.k.a. Cpd1, PhapIII) has been conserved throughout vertebrate evolution, suggesting that it has an important function in
organismal survival.
Principal Findings: Here, we demonstrate that the Anp32e gene can be deleted in mice without any apparent effect on
their wellbeing. No defects in thymocyte apoptosis in response to various stresses, fibroblast growth, gross behaviour,
physical ability, or pathogenesis were defined. Furthermore, combined deletion of Anp32a and Anp32e also resulted in a
viable and apparently healthy mouse.
Significance: These results provide evidence that significant functional redundancy exists among Anp32 family members.
Citation: Reilly PT, Afzal S, Wakeham A, Haight J, You-Ten A, et al. (2010) Generation and Characterization of the Anp32e-Deficient Mouse. PLoS ONE 5(10):
e13597. doi:10.1371/journal.pone.0013597
Editor: Alfred Lewin, University of Florida, United States of America
Received April 20, 2010; Accepted October 1, 2010; Published October 26, 2010
Copyright:  2010 Reilly et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was partially supported by the Prostate Cancer Research Foundation of Canada and the U.S. Department of Defense award number
PC020806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: tmak@uhnres.utoronto.ca
¤a Current address: Department of Radiation Oncology, University Hospital Zu ¨rich, Zu ¨rich, Switzerland
¤b Current address: Samuel Lunenfeld Research Institute, Toronto, Ontario, Canada
Introduction
The acidic nuclear phosphoprotein 32 kilodalton (Anp32)
proteins are metazoan-specific factors that have been implicated
in the regulation of a panoply of cellular functions, including
proliferation [1,2,3,4,5], apoptosis [6,7,8,9,10,11,12,13], and
differentiation [14,15,16,17,18]. Diverse Anp32 family members
exert their functions by modulating phosphatase activity
[19,20,21], mRNA stability [22,23,24], intracellular transport
[22,25,26], caspase activation [8,9,10,11], and/or chromatin
modification [27,28,29]. Based on this accumulated literature, it
is probable that the Anp32 factors control multiple cellular
activities in a broad range of physiological contexts.
The mammalian Anp32 family is comprised of Anp32a (also
known as LANP, pp32, I2PP2A, or PHAPIa), Anp32b (a.k.a.
APRIL, PAL31, or PHAPIb), and Anp32e (a.k.a. Cpd1 or
PhapIII) [30,31]. All Anp32 proteins share two regions of amino
acid conservation: the N-terminal leucine-rich repeat (LRR)
domain and the C-terminal acidic tail. Although the Anp32
LRR domain resembles the protein-protein interaction domains of
many other protein families, the Anp32 acidic tail is highly
unusual in its amino acid composition [31]. The Anp32 acidic tail
contains .100 amino acids, of which .80% are glutamate or
aspartate residues. However, this sequence is not unique to the
Anp32 family, as short conserved acidic regions resembling the
Anp32 acidic tail can be found in the Anp32-binding partner the
SET translocation protein [31].
Anp32eistheleastwell-characterizedmemberofthemammalian
Anp32 family. Anp32e was originally cloned as a gene upregulated
in the mouse brain upon postnatal development, which led to
suggestions that it might play a role in neuronal proliferation and
differentiation [16]. Anp32e wasalsoidentifiedas having a potential
oncogenic function in gastric cancer [32] and myeloma [33], but
then was linked to favorable treatment outcomes in patients with
follicular lymphoma [34]. Biochemical studies have indicated that
Anp32e is a positive regulator of caspase activation in the
apoptosome. Like other Anp32 family members, Anp32e can
reduce the dATP required during apoptosome formation to
conform with physiological levels of this nucleotide [9].
Despite the evolutionary conservation of Anp32 family
members among metazoans, mutation of the Anp32 genes does
not appear to affect embryogenesis. Flies bearing a validated
mutation of mapmodulin, the Drosophila homologue of Anp32,
are viable [35]. In mice, deletion of Anp32a results in no
detectable health deficits or defects in neuronal function [36]. In
humans, no mutations in any Anp32 family members have been
linked to hereditary disorders. This lack of phenotype across
multiple species has led to the hypothesis that the three
mammalian Anp32 orthologues are functionally redundant such
that no one factor is essential for development.
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13597In this study, we confirm that the Anp32e gene can be deleted in
mice without any apparent effect on their wellbeing. No defects in
cellular growth, apoptosis, or neurological functions could be
found. Furthermore, combined deletion of Anp32a and Anp32e
also resulted in a viable and apparently healthy mouse. These
results provide strong evidence that significant functional redun-
dancy exists among Anp32 family members.
Results
Generation of Anp32e-deficient mice
To determine whether Anp32e had a unique biological role, we
generated a targeting construct that resulted in the constitutive
elimination of Anp32e exons 2–5 in one clone of murine ES cells
(Figure 1A). Southern blotting of fetal mouse DNA using flanking
probes confirmed the deletion of exons 2–5 (Figure 1B). Mutant
mice were generated by standard blastocyst injection and
backcrossed for six generations into the C57BL6 background.
Quantitative RT-PCR analysis of mRNA from MEFs and
thymocytes from Anp32e
+/+ and Anp32e
2/2 mice showed that
no transcripts were expressed from the targeted Anp32e allele
(Figure 1C). Using the same cDNA preparations to test for
Anp32a and Anp32b mRNA expression, we found that these
transcripts may be induced by deletion of Anp32e, particularly in
thymocytes (Figure 1C). To more closely examine this potential
induction, we tested whether protein levels of Anp32a and Anp32b
were also increased in Anp32e
2/2 thymocytes. As shown in
Figure 1D, there was no evident compensatory induction of either
Anp32a or Anp32b protein levels in the absence of Anp32e.
We attempted to generate monoclonal and polyclonal antisera
specific for Anp32e to confirm the loss of Anp32e protein in our
mutant mice. Unfortunately, none of the antisera tested produced
a positive signal of the expected size when used in standard
immunoblotting. Procurement of additional antisera and oligo-
bodies courtesy of Dr. Martı ´n Radrizzani [16] resulted in western
blot bands of identical sizes in extracts of Anp32e
+/+ and
Anp32e
2/2 MEFs and splenocytes (data not shown), suggesting
that the protein detected here and in previous reports was not
Anp32e.
Anp32e-deficient mice are viable and fertile
A colony of Anp32e
+/2 mice of mixed genetic background was
established to determine the phenotypic impact of loss of Anp32e
function. Interbreeding of Anp32e
+/2 mice produced Anp32e
2/2
mice at the expected Mendelian ratio, at least at time of weaning
(3–4 weeks of age; Table 1). When mice in this colony were
examined for fertility, we found that both male and female
Anp32e
2/2 mice of 6–40 weeks of age were able to produce
normal-sized litters at normal frequencies when bred to their
Anp32
+/2 counterparts (data not shown). These findings suggest
that loss of Anp32e function does not deleteriously affect the
development or fertility of mice under normal laboratory
conditions.
Anp32e
2/2 cells show normal rates of proliferation and
apoptosis
Because the Anp32 proteins have been linked to cell
proliferation, we examined whether there was any difference in
proliferation rates between Anp3e
+/+ and Anp32e
2/2 cells. We
isolated primary MEFs from Anp32e
+/+, Anp32e
+/2 and
Anp32e
2/2 mice from a single litter of C57/BL6 congenic
animals and examined their growth in vitro. No differences were
detected in a two-day analysis (Figure 2A). Furthermore, an
absence of Anp32e did not alter the kinetics of release of MEFs
from serum starvation-induced arrest (data not shown). These data
suggest that Anp32e does not play a unique role in proliferation
under either normal or low serum conditions.
Anp32e has been identified as an activator of apoptosome-
mediated proteolysis [9]. To test whether Anp32e-deficient cells
were defective in intrinsic apoptotic signaling, we isolated
thymocytes from Anp32e
+/+ and Anp32e
2/2 mice and exposed
them to various apoptotic stimuli. As shown in Figure 2B, these
thymocytes responded in equivalent fashion to both intrinsic and
extrinsic apoptotic stimuli, suggesting that Anp32e does not play a
unique role in apoptosis.
Anp32e-deficient mice demonstrate no apparent
neurological defects
It has been suggested that Anp32 proteins might play roles in
brain development [16,37]. To test this hypothesis in our mutant
mice, we first performed gross histological examinations of the
brains of C57BL/6-congenic Anp32e
2/2 and Anp32e
+/+ mice. We
found no structural differences between wild-type and mutant
brains, and the sizes and cellularity of variousregions of these brains
were comparable (data not shown). We then tested Anp32e
2/2 and
Anp32e
+/+ mice for stimulatory responses in qualitative examina-
tions and found that hearing and whisker stimulation evoked similar
responses in both strains. Finally, we examined the relative abilities
of these animals to perform in a timed Rotarod suspension assay.
There was no statistically significant difference between the mean
time that Anp32e
2/2 mice were able to remain suspended (126 sec)
and the mean suspension time of Anp32e
+/+ littermates (151 sec;
Figure 3). Thus, a lack of Anp32e does not impair balance and
motor control in mice.
Anp32e-deficient mice demonstrate no specific
pathologies
Because our Anp32e-deficient mice showed no apparent deficits
in any of the functions proposed for Anp32e, we expanded our
phenotypic analyses and used standard assays of blood chemistry
and hematology to perform a broad-spectrum analysis of internal
organ function. No statistically significant differences between sex-
matched Anp32e
+/+ and Anp32e
2/2 littermates at 4–8 weeks of
age were detected in clinical chemistry (Table 2, top), suggesting
that the functions of the liver [as defined by albumin, alanine
transaminase (ALT), and aspartate transaminase (AST) levels], the
heart [as defined by creatine kinase (CK) and lactate dehydroge-
nase (LDH) levels], the pancreas [as defined by amylase and
glucose levels], and the kidney [as defined by creatinine, uric acid,
and ion levels] are not significantly affected by loss of Anp32e.
Furthermore, gross hematological examination demonstrated no
differences in leukocyte or erythrocyte counts (Table 2, bottom),
suggesting that Anp32e deficiency has no effect on basic blood
constituents. When heart function was examined using ECG, the
results obtained for Anp32e
2/2 mice were within normal
variability (data not shown).
To search for a function of Anp32e in preventing disease, we
allowed Anp32e
+/2 and Anp32e
2/2 littermate mice of a mixed
background to age and monitored them for susceptibility to early
disease onset. We found that 5/6 Anp32e
2/2 mice were still alive
at 80 weeks of age when the experiment was terminated; this
proportion was similar to that in the Anp32e
+/2 group (data not
shown). None of the mutants showed any gross defects or tissue
pathologies. These results indicate that either the function of
Anp32e is redundant with that of another molecule, or that its
unique function will only be revealed by the application of an
unusual stress yet to be determined.
Anp32e Deletion in Mice
PLoS ONE | www.plosone.org 2 October 2010 | Volume 5 | Issue 10 | e13597Figure 1. Generation and Validation of Anp32e-deficient mice. A. Targeting of the Anp32e gene. The diagram shows the murine genomic
Anp32e locus and the targeting construct that replaced exons 2 to 6 with a pgk-neo cassette. Regions of homology in the targeting construct are
shaded. Stu, StuI sites used for Southern blotting. Hind, HindIII sites used for Southern blotting of neo. FP, flanking probe. The sizes of the diagnostic
Stu1 fragments for the wild-type Anp32e allele (3.1 kb) and the targeted Anp32e allele (1.5 kb) as well as the diagnostic HindIII fragment for neo
insertion (4.1 kb) are shown. B. Confirmation of deletion. DNA from fetal Anp32e
+/+ (wt), Anp32e
+/2 (E
+/2), and Anp32e
2/2 (E
2/2) mice was subjected
to Southern blotting using the flanking probe in shown in diagram 1A (within intron 6). DNA from Anp32e
+/+ (wt) and Anp32e
+/2 (E
+/2) ES cells was
also subjected to southern blotting with a neo probe in order to confirm a single vector insertion. C. Validation of Anp32e mRNA deficiency.
Quantitative RT-PCR of mRNA from primary MEFs from Anp32e
+/+, Anp32e
+/2 and Anp32e
2/2 embryos at E14.5, and (bottom) thymocytes from
Anp32e
+/+, Anp32e
+/2 and Anp32e
2/2 mice at 4–8 weeks of age. Expression levels of Anp32a (black bars), Anp32b (grey bars), and Anp32e (white
Anp32e Deletion in Mice
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viability
In a further attempt to delineate Anp32e’s physiological role, we
decided to create double mutant Anp32e
2/2;Anp32a
2/2 mice.
First, we generated a novel strain of Anp32a
2/2 mice (Figure 4).
Deletion of the genomic sequence was confirmed by Southern
blotting using a flanking probe as well as a neomycin probe
(Figure 4B). Anp32a protein deletion was confirmed by immuno-
blot analysis of liver and spleen extracts using a polyclonal anti-
APRIL antibody [23] that crossreacts with Anp32a (Figure 4C).
Consistent with a previous report [36], we found no difference in
viability of the Anp32a mutation in either a mixed or backcrossed
C57BL6 background (data not shown). To examine potential
physiological changes in Anp32a-deficient cells, we performed
growth curve analysis on early-passage mixed-bred Anp32a2/2
embryo fibroblasts (Figure 5). We found no significant difference in
net proliferation in this analysis.
We then bred our Anp32e
+/2 animals to our Anp32a
+/2 mice
to generate double mutant progeny of a mixed 129Ola:C57BL6
background, and intercrossed the double heterozygotes to examine
all potential genotypes. We found that the Anp32e
2/2 genotype
was present at the expected Mendelian ratio in both in the
Anp32a
+/2 and Anp32a
2/2 backgrounds (Table 3). In fact, no
statistically significant deviations from expected Mendelian ratios
were observed for this breeding in its entirety. Investigation of a
small number of litters showed that both males and females of the
Anp32a
2/2;Anp32e
2/2 genotype were fertile and able to produce
litters of normal size and gross phenotype.
Discussion
Like other Anp32 family members, Anp32e has been conserved
throughout vertebrate evolution, suggesting that it has an
important function in organismal survival. However, our study
demonstrates that ablation of Anp32e in mice does not affect their
development or general health. Even the application of apoptotic
stresses, behavioural tests, and aging experiments failed to elicit a
phenotype for Anp32e-deficient animals. Although we do not
claim that our analyses were exhaustive, we have performed a
broad range of experiments designed to reveal effects on all
currently reported functions of Anp32e.
Our work has raised an issue with respect to interpreting prior
studies on Anp32e, particularly those based on the use of
antibodies and oligobodies. Our investigation showed that tissues
from a mutant mouse whose Anp32e deficiency was validated by
quantitative RT-PCR produced an identical band pattern to that
of wild-type tissues upon western blotting. Such a result suggests
that the antibody and oligobody used in previous publications
[16,19] may not recognize Anp32e at all but rather an unknown
factor(s).
Anp32e is the second Anp32 family member whose deletion in
mice results in no apparent phenotype. Two independent loss-of-
function alleles of Anp32a have now been tested in mice and have
yielded no phenotype [36]. These findings all point to a probable
functional redundancy of Anp32 genes, consistent with the
conservation of specific protein domains among family members.
Although functional redundancy with other Anp32 family
members is one possible explanation for the survival of Anp32
single mutants, the conservation of all three factors across species
suggests that these genes do indeed have individual independent
functions. The in vivo function(s), as elucidated from knockout
analyses, may only be activated in response to stresses that remain
Table 1. Expected and attained Mendelian ratios of progeny
derived from the intercrossing of Anp32e
+/2 mice.
genotype
Anp32e
+/+ Anp32e
+/2 Anp32e
2/2
expected 8.5 (25%) 17 (50%) 8.5 (25%)
attained 10 (29.4%) 16 (47.0%) 8 (23.5%)
Data shown are the number of mice of a given genotype (percentage of total
progeny). Chi square analysis determined that there was no significant
difference from expected ratios.
doi:10.1371/journal.pone.0013597.t001
Figure 2. Normal proliferation and apoptosis of Anp32e
2/2
cells. A. Growth curves of primary MEFs from Anp32e
+/+, Anp32e
+/2
and Anp32e
2/2 mice (n=2/genotype). Nt/N0, cell number at time
point/cell number on day 0. B. Apoptosis of Anp32e
+/2 and Anp32e
2/2
thymocytes after 20 hours in culture response to (left to right): –ve,
untreated controls, UV-irradiation (30 mJ/cm
2 and 60mJ/cm
2), c-
irradiation (1 Gy and 2 Gy), etoposide (1 mM and 3 mM), dexamethasone
(3 nM and 10 nM), and staurosporine (1 mM and 3 mM). Results shown
are mean % viable cells 6 SD (n=3/genotype).
doi:10.1371/journal.pone.0013597.g002
bars) mRNAs are shown relative to levels in Anp32e
+/+ mice. Error bars represent the standard deviation from the mean across three technical
replicates per sample. D. Absence of compensatory induction of other Anp32 proteins. Protein extracts from lymphocytes of Anp32e+/+ (wt) and
Anp32e2/2 (E2/2) mice were probed for Anp32a, Anp32b, and beta-tubulin expression.
doi:10.1371/journal.pone.0013597.g001
Anp32e Deletion in Mice
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overlap of the Anp32 genes exists to ensure that potentially
catastrophic developmental errors are overcome.
Materials and Methods
Mice
Mice were maintained under SPF conditions in individually
ventilated cages and fed 5% irradiated meal. Unless otherwise
noted, all Anp32
2/2 mice analyzed in this study were derived
from a single clone of embryonic stem (ES) cells and backcrossed
six generations into the congenic C57/BL6 background.
Plasmids and primers
Sequences directing the expression of Diphtheria toxin A in mouse
ES cells were cloned into pBluescript (pgk-neo) [38] to give the
plasmid pBSneoDTA. Regions of the Anp32e gene adjacent to the
targeted exons werecloned by high fidelity PCR. The primers GGG-
GTCGACCGTGAAATCGAGGGACAGGGGTCCGC and GG-
GGGATCCCAGACCCTTCGGTGTCTAAGCATTCTAAACG-
CATG were used to clone the upstream arm of homology between
the SalI and BamHI sites. The primers GGGCCGCGTAAACTG-
GCCTTGAGGTGAGACCAGTGG and GGGGCGGCCGCG-
AGTGCTGGGATTAAAGGCGTGCGCCACC were used to
clone the downstream arm of homology between the XbaI and
NotI sites. Homologous regions of Anp32a adjacent to the targeted
exons were cloned as the EcoRV-XbaI fragment upstream of exon 2
and the XbaI-EcoRV fragment downstream of exon 4.
Gene targeting
Targeting constructs were linearized and transfected by electro-
poration into E14K mouse ES cells as previously described [39].
Homologous recombinants were selected by culture in 0.3 mg/ml
G418 for 10–14 days and screened for appropriate integration by
PCR and southern blotting as previously described [38,39].
Southern blotting
Southern probes used to detect Anp32 genomic sequences were
amplified from genomic ES DNA. Primer pair sequences were as
follows: Anp32e, CCTGTGAATGTGTGGCGTGTGAATGTAG
and TTTCCCACTCAATGCACTGGCTCTTAGA; Anp32a,
CCATGGATTCTGTGACCCTTCAGCC and CCCAAGTCA-
CCTACCATTGCACCC.GenomicDNAwasdigested,resolvedon
gels, transferred to nylon membranes, and hybridized to the above
probes using standard procedures [38,39]. To optimize image sizing,
some figures have been adjusted so that desired lanes appear beside
one another.
Quantitative RT-PCR
RNA from adult mouse tissues was isolated using a commercial
kit and protocol (Qiagen). cDNA was reverse-transcribed from
1 mg mRNA using Superscript II enzyme (Invitrogen), and
analyzed by Syber-Green nucleotide incorporation in separate
PCR reactions. Primers were:
Gapdh (loading control), AACAGGAAGCCCATCACATCTT
and GCCCTTCCACAATGCCAAAGTT; Anp32a, GCGAAA-
ACAGAATCTCAGGGG and TTCTTCAGCGGCTCTATT-
GTG; Anp32b, AGCCGTTCGAGAACTTGTCTT and CAG-
GTTATTGCCACTTAGGTTCA; Anp32e, AATTGCTTGTG-
TGTCAATGGGG and GGCCATGCTAAGAAACTCCAG.
Western blotting
Immunoblotting to detect Anp32a was performed on 5 mg
protein extracted by NP-40 detergent lysis of homogenized mouse
Table 2. Clinical chemistry and hematology comparisons of 4
pairs of Anp32e
+/2 and Anp32e
2/2 littermate mice.
Anp32e
+/+ Anp32e
2/2
Clinical
chemistry
Albumin (g/L) 35.361.7 35.561.7
ALT (Units/L) 25.866.0 31.663.6
AST (Units/L) 50.864.3 53.065.6
CK (Units/L) 192.5692.4 373.86211.7
LDH (Units/L) 397.3648.9 466.0680.3
Amylase (Units/L) 2478.86358.3 2604.56515.6
Cholesterol (mM) 3.060.6 2.960.7
Triglycerides (mM) 0.760.1 0.760.2
Glucose (mM) 12.961.1 11.161.3
Creatinine (c) 16.361.5 11.365.1
Uric Acid (mM) 65.8618.6 61.5619.2
Na
+ (mM) 147.061.8 145.062.0
K
+ (mM) 5.460.3 5.560.6
Cl
- (mM) 107.561.7 107.060.0
Hematology RBC (billions/mL) 11.160.5 11.160.3
HgB (g/L) 166.867.8 161.566.2
HCT (L/L) 0.4960.02 0.4860.02
MCV (fL) 43.760.3 43.060.9
MCH (pg/cell) 15.060.2 14.660.3
MCHC (g/L) 342.363.0 340.063.4
PLT (millions/mL) 11466200 1221670
WBC (millions/mL) 15.660.9 15.360.7
Data shown are the mean levels of the indicated parameters 6 SD (n=4/
genotype). ALT , Alanine transaminase. AST, Aspartate transaminase. CK,
Creatine kinase. LDH, Lactose dehydrogenase. Na
+, Sodium. K
+, Potassium. Cl
-,
Chloride. HgB, Hemoglobin. HCT, Hematocrit. MCV, Mean corpuscular volume.
MCH, Mean corpuscular hemoglobin. MCHC, Mean corpuscular hemoglobin
concentration. PLT, Platelet count. WBC, White blood cell count.
doi:10.1371/journal.pone.0013597.t002
Figure 3. Normal rotorod behaviour. Individual Anp32e
+/+ and
Anp32e
2/2 mice (spherical symbols) were placed on a rotating rotorod
and the time they remained suspended was measured in seconds.
Horizontal bars, mean duration per genotype.
doi:10.1371/journal.pone.0013597.g003
Anp32e Deletion in Mice
PLoS ONE | www.plosone.org 5 October 2010 | Volume 5 | Issue 10 | e13597Figure 4. Generation and Validation of Anp32a-deficient mice. A. Targeting of the Anp32a gene. The diagram shows the murine genomic
Anp32a locus and the targeting construct that replaced exons 2 to 5 with a pgk-neo cassette. Regions of homology in the targeting construct are
shaded. RV, EcoRV; X, XbaI; Spe, SpeI; FP, flanking probe used for Southern blot analysis. B. Confirmation of deletion. DNA from embryos of Anp32a
+/+
(wt), Anp32a
+/2 (A
+/2) and Anp32a
2/2 (A
2/2) was subjected to Southern blotting using the flanking probe in A (within intron 1). Anp32a
+/+(wt) and
Anp32a
+/2 (A
+/2) ES-cell DNA was also probed for the neomycin resistance gene (Neo probe). C. Validation of Anp32a protein deficiency by
immunoblotting of extracts from mouse liver and spleen. Primary anti-APRIL antibody raised in mice against recombinant human Anp32b protein
recognizes both the murine Anp32b protein and the Anp32a protein, which can be distinguished by size. Tubulin, loading control. *, non-specific
bands seen in liver and spleen.
doi:10.1371/journal.pone.0013597.g004
Anp32e Deletion in Mice
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were transferred to PDVF membranes and probed with anti-b-
tubulin (loading control; Li-Cor Bioscience), anti-APRIL antibody
that detected both the Anp32a and Anp32b proteins (courtesy of
Dr. Imed Gallouzi, McGill University, Montreal, Canada) [23],
anti-Anp32a (sc-5652, Santa Cruz Biotech), or anti-Anp32b
(10843-1-AP, Proteintech). Bands on blots were visualized
according to Li-Cor Odyssey standard protocols.
Rotorod analysis
Four littermate pairs of Anp32e
+/+ and Anp32e
2/2 male mice
(4–8 weeks old) were examined for their ability to stay on the
Economex Rota Rod when the apparatus was operating at an
initial speed of 4 rpm that subsequently increased at a rate of
0.1 rpm/second. Each mouse was tested three times with a 15 min
rest period between tests.
Clinical chemistry, hematology and electrocardiography
Blood was extracted from the saphenous vein of 4 pairs of
Anp32e
+/+ and Anp32e
2/2 male littermates at 4–8 weeks of age.
Samples were sent to IDEXX Laboratories Inc. for commercial
analysis of wide spectrum clinical chemistry. Additional blood
samples from the same mice were tested for hematological
differences using a Coulter A
cNT diff Analyzer (Coulter Corp.).
Electrocardiograms (ECG) were generated for these same mice
using the Power Lab/4SP system with ML135 and MLA0112
attachments (AD Instruments). The 5 electrodes of this apparatus
were connected subcutaneously at the limbs. The ECG were
analyzed using the SAECG extension for Chart 4 (AD
Instruments).
Apoptosis
Apoptosis assays were performed as described previously
[39,40]. Briefly, single cell suspensions were prepared of total
thymocytes from three sex-matched littermate pairs of Anp32e
+/+
and Anp32e
2/2 mice (4–8 weeks old). The cells were exposed to
apoptotic stimuli as detailed in Figure 2B and then cultured
overnight in RPMI medium containing penicillin/streptomycin,
10% fetal bovine serum (FBS) and L-glutamine. Viability was
determined by propidium iodide [16] exclusion and flow
cytometry using a FACScaliber (BD Pharmingen).
Growth curves
Growth curves were established as described previously [41].
Briefly, primary murine embryonic fibroblasts (MEFs) were
derived from 2 embryos/genotype (Anp32e
+/+, Anp32e
+/2,
Anp32e
2/2) on embryonic day 14.5 (E14.5). MEFs were cultured
in Dulbecco’s MEM containing penicillin/streptomycin, 10%
FBS, L-glutamine, and beta-mercaptoethanol. After two passages,
Figure 5. Growth Curve of Anp32a-deficient fibroblasts. Growth
curves of early passage primary MEFs from littermate isolates of
Anp32a
+/+ and Anp32a
2/2 embryos. Two isolates per genotype to give
four littermate MEF lines total. Nt/N0, cell number at time point/cell
number on day 0.
doi:10.1371/journal.pone.0013597.g005
Table 3. Expected and attained Mendelian ratios of progeny derived from the intercrossing of Anp32e
+/2;Anp32a
+/2 double
mutant littermate mice.
Genotype
Anp32a
+/+;
Anp32e
+/+
Anp32a
+/+;
Anp32e
+/2
Anp32a
+/+;
Anp32e
2/2
Anp32a
+/2;
Anp32e
+/+
Anp32a
+/2;
Anp32e
+/2
Anp32a
+/2;
Anp32e
2/2
Anp32a
2/2;
Anp32e
+/+
Anp32a
2/2;
Anp32e
+/2
Anp32a
2/2;
Anp32e
2/2
Expected 2 (7.4%) 3 (11.1%) 2 (7.4%) 3 (11.1%) 7 (25.9%) 3 (11.1%) 2 (7.4%) 3 (11.1%) 2 (7.4%)
Attained 3 (11.1%) 6 (22.2%) 3 (11.1%) 3 (11.1%) 3 (11.1%) 6 (22.2%) 1 (3.7%) 0 (0%) 2 (7.4%)
Data shown are the number of mice of a given genotype (percentage of total progeny). Chi square analysis determined that there was no significant difference from
expected ratios.
doi:10.1371/journal.pone.0013597.t003
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4 cells/well in 6-well dishes. For
serum deprivation studies, the medium was replaced the next day
(Day 0) with medium containing 0.1% FBS. For quantitation,
triplicate wells for each genotype and each time point (day 0, 1 or
2) were washed in PBS and trypsinized. Cells were collected in
specified volumes and counted on a hemocytometer. To eliminate
small variations in seeding and plating efficiency, growth was
normalized to the initial cell count on Day 0.
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